Pfizer Heads BMI's Asia Pharmaceutical Sales Ranking For Q210

BMI View: Asia is the most promising region for pharmaceutical companies. Combined sales of prescription drugs and over-the-counter (OTC) medicines are forecast to increase from US$207bn in 2009 to US$290bn in 2014, equating to a compound annual growth rate (CAGR) of 6.98%. Key drivers of growth are booming economies, greater government involvement in healthcare and a higher prevalence of chronic diseases.

To read the full article, please choose one of the following options: